ArticleCancer immunology, immunotherapy : CII2022

Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.

Ruiting Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.